Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-05-29 @ 11:58 AM
Study NCT ID:
NCT05107856
Status:
TERMINATED
Last Update Posted:
2024-01-31
First Post:
2021-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
Sponsor:
Prelude Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia | View |
| None | B-cell Non-Hodgkin Lymphoma | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Chronic Myelomonocytic Leukemia | View |
| None | Follicular Lymphoma | View |
| None | Mantle Cell Lymphoma | View |
| None | Marginal Zone Lymphoma | View |
| None | Myelodysplastic Syndromes | View |
| None | Myeloproliferative Neoplasm | View |
| None | Small Lymphocytic Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia (AML) | View |
| None | Azacitidine | View |
| None | B-cell Malignancies | View |
| None | B-cell Non-Hodgkin lymphoma | View |
| None | Chronic lymphocytic leukemia (CLL) | View |
| None | Chronic Myelomonocytic Leukemia (CMML) | View |
| None | Follicular Lymphoma | View |
| None | Hematologic Malignancies | View |
| None | Mantle Cell Lymphoma | View |
| None | Marginal Zone Lymphoma | View |
| None | Myelodysplastic Syndromes (MDS) | View |
| None | Myeloid cell leukemia-1 (MCL-1) | View |
| None | Myeloproliferative Neoplasm (MPN) | View |
| None | PRT1419 | View |
| None | Relapsed/Refractory Myeloid | View |
| None | Small lymphocytic lymphoma (SLL) | View |
| None | Venetoclax | View |